Boston, USA-based biotech Aera Therapeutics, which is harnessing next-generation enabling delivery technologies and precision ...

Denmark, oncology-based Pharmacosmos today announced that it has assumed the worldwide rights, excluding select Asia-Pacific ...

US pharma major Eli Lilly (NYSE: LLY) announced a significant expansion of its long-standing alliance with Purdue University, ...

N) today presented data from the Phase III REAL8 basket study, which showed that once-weekly Sogroya (somapacitan) was ...

Shine Technologies, a private nuclear fusion corporation based in Wisconsin, USA, has entered into a definitive agreement to ...

UK-based pharma major AstraZeneca (LSE: AZN) has started construction on a new manufacturing site for small molecule drugs in ...

The UK’s BioIndustry Association (BIA) has publishes its 10-year Vision for the UK life science sector called “A Vision for ...

Sylentis, a wholly-owned subsidiary of Spanish drugmaker PharmaMar (MSE: PHM), announced top-line results from the SYL1801-II ...

New figures from European industry group EFPIA paint a stark picture of the growing divide in access to innovative medicines ...

American health officials have recommended temporarily halting the use of Ixchiq (chikungunya virus vaccine, live) in people ...

The Indian subsidiary of UK pharma major AstraZeneca has announced a Central Drugs Standard Control Organization (CDSCO) approval to import for sale and distribution of trastuzumab deruxtecan ...

US President Donald Trump sent shivers through the pharmaceutical industry as he vowed to dramatically reduce the high drug prices that have long been a feature of the US market.